Monsanto Company and Novozymes have formed a long-term strategic alliance to transform research and commercialisation of sustainable microbial products that will provide a new platform of solutions for growers around the world.
The BioAg Alliance will allow the companies to leverage employees, technologies and commercial assets in the companies’ agricultural biologicals portfolios.
The BioAg Alliance is unique in the industry, bringing together Novozymes’ commercial BioAg operations and capabilities within microbial discovery, development and production with Monsanto’s microbial discovery, advanced biology, field testing and commercial capabilities. The result will be a comprehensive research, development and commercial collaboration to help farmers globally meet the challenge of producing more with less in a sustainable way, for the benefit of agriculture, consumers, the environment and society at large.
“As the world population grows at tremendous pace over the next decades, we need to significantly increase the output from our land without increasing the pressure on the environment,” said Peder Holk Nielsen, CEO of Novozymes. “The combined capabilities of Novozymes and Monsanto create an innovation powerhouse with a unique opportunity and approach to unleash the transformational opportunity in naturally derived microbial solutions in agriculture.”
Source: Monsanto
© FoodBev Media Ltd 2024